The Clinical and Translational Science Collaborative (CTSC) of Cleveland is a collaborative venture among five Cleveland health institutions - Case Western Reserve University, the Cleveland Clinic, University Hospitals, MetroHealth Medical Center, and the Veterans Administration Medical Center, as well as community partners. CTSC achieved prior goals of uniting as a collaborative, developed informatics tools, resource sharing, and institutional commitments to enhance the collaborative. Consolidation and catalytic activities begun in the last grant period will be continued. Moreover, CTSC will continue rigorous evaluation of both its operations and progress toward larger goals. CTSC has set three new goals for the next grant period. 1) Translation 1 research will be enhanced. Infrastructure in support of identification and structural determination of therapeutic targets, as well as high through put screening will be implemented. Support systems to assist in patient based research both recruitment and testing will be streamlined and strengthened. Critically, CTSC will create support systems to guide development of potential human therapeutics and diagnostics from discovery to use in man, 2) CTSC will improve health parameters in Cleveland, one of America's poorest and least healthy cities. Community Research Partnership Core is querying the community via neighborhood focus groups to determine their health priorities. At least one of these priorities, and others selected based on the strengths of our CTSC investigative community, will be targeted for special effort. One practice based research network has already succeeded in reducing HgbAlc in 27,000 diabetics in Cleveland by one percentage point in three years, raising optimism that this project can indeed move the needle. 3) CTSC interactions with the national CTSA community will increase. The initial focus of CTSC was inward, establishing connections and catalyzing change in our home institutions, but in the next grant period the CTSC will increase interactions around the consortium. A primary focus will be the Ohio Consortium ofthe three Ohio CTSAs (CTSC, Columbus, Cincinnati), which currently collaborate surrounding child health and cancer projects, and on the web site NetWellness, which has been expanded from simply providing unbiased medical information to include descriptions of clinical research and access to clinical trials. In the next grant period goals will include extending the CTSC IRB electronic hub for facilitated review to include the other CTSA sites, increasing project collaboration, and connecting patient databases via Explorys, a web based informatics tool utilizing the electronic health record.
The CTSC is highly relevant to human health. Using the Cleveland biomedical community as a prototype, we will develop and test electronic and other strategies for coordinating research functions among different institutions, such as IRB approval and facile data sharing. Using the Cleveland community as a laboratory and our practice based research networks and community partnership resource as tools, we will seek to improve health parameters in Cleveland. We will also develop more facile means for Translation 1.
|Valls, L; Badve, C; Avril, S et al. (2016) FDG-PET imaging in hematological malignancies. Blood Rev 30:317-31|
|Wang, Zeneng; DiDonato, Joseph A; Buffa, Jennifer et al. (2016) Eosinophil Peroxidase Catalyzed Protein Carbamylation Participates in Asthma. J Biol Chem 291:22118-22135|
|Cummings, Linda C; Kou, Tzuyung Doug; Schluchter, Mark D et al. (2016) Outcomes after endoscopic versus surgical therapy for early esophageal cancers in an older population. Gastrointest Endosc 84:232-240.e1|
|VanDevanter, Donald R; Morris, Nathan J; Konstan, Michael W (2016) IV-treated pulmonary exacerbations in the prior year: An important independent risk factor for future pulmonary exacerbation in cystic fibrosis. J Cyst Fibros 15:372-9|
|Berggren, Erica K; Groh-Wargo, Sharon; Presley, Larraine et al. (2016) Maternal fat, but not lean, mass is increased among overweight/obeseÂ women with excess gestational weight gain. Am J Obstet Gynecol 214:745.e1-5|
|Hudson, Chantelle D; Savadelis, Alyssa; Nagaraj, Anil Belur et al. (2016) Altered glutamine metabolism in platinum resistant ovarian cancer. Oncotarget 7:41637-41649|
|Thomas, George; Xie, Dawei; Chen, Hsiang-Yu et al. (2016) Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study. Hypertension 67:387-96|
|Alapan, Yunus; Fraiwan, Arwa; Kucukal, Erdem et al. (2016) Emerging point-of-care technologies for sickle cell disease screening and monitoring. Expert Rev Med Devices 13:1073-1093|
|Kalhan, Satish C; Gruca, Lourdes; Marczewski, Susan et al. (2016) Whole body creatine and protein kinetics in healthy men and women: effects of creatine and amino acid supplementation. Amino Acids 48:677-87|
|Thomas, Holly N; Evans, Gregory W; Berlowitz, Dan R et al. (2016) Antihypertensive medications and sexual function in women: baseline data from the SBP intervention trial (SPRINT). J Hypertens 34:1224-31|
Showing the most recent 10 out of 1186 publications